Michigan Heart — Ypsilanti, Michigan

Michigan Heart is a clinical research site located in Ypsilanti, Michigan, United States 48197.

Crixeo Clinical Trials Trust Score: 86/100 (GOOD). This profile has not yet been claimed by the site owner.

Michigan Heart has participated in 40 clinical trials with 11 currently active.

Therapeutic areas: Peripheral Artery Disease, Coronary Artery Disease (CAD), Heart Failure With Reduced Ejection Fraction.

Sponsors: C. R. Bard, Astellas Pharma Global Development, Inc., Cytokinetics.

Sponsor Feasibility Report

Trust Score: 86/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Michigan Heart?

Michigan Heart has a Crixeo Trust Score of 86/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Michigan Heart conducted?

Michigan Heart has 40 clinical trials on record, with 11 currently active. Their work covers Peripheral Artery Disease, Coronary Artery Disease (CAD), Heart Failure With Reduced Ejection Fraction.

Is Michigan Heart accredited by Crixeo Clinical Trials?

Michigan Heart has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Michigan Heart?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.